Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03673228 · ClinicalTrials.gov registry record · NA
Preventing Smoking Relapse After Total Joint Replacement Surgery
A NA study, sponsored by NYU Langone Health.
- Completed
- Registry status
- NA
- Development phase
- 21
- Enrollment target
NCT03673228 is a NA study that has completed, run by NYU Langone Health. The registered enrollment target is 21 participants.
The verdict
NCT03673228, a NA study, has completed, sponsored by NYU Langone Health.
- COMPLETED
- Registry status
- NA
- Development phase
- 21 participants
- Enrollment target
Study Summary
Hospitalization for elective knee or hip replacement surgery presents an outstanding opportunity to motivate people to quit smoking, because it provides an opportunity to encourage patients to remain smoke-free as they proactively quit to optimize their surgery outcomes. This study will conduct a comparative effectiveness trial of patients who quit smoking pre-operatively, comparing the current standard of care with a novel comprehensive relapse prevention intervention guided by Marlatt's Relapse Prevention Model.
Interventions
- DRUG Nicotine Replacement Therapy (NRT)
- BEHAVIORAL Standard Treatment Counseling
- BEHAVIORAL Comprehensive Relapse Prevention Intervention
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 21 participants |
| Start Date | 2019-01-15 |
| Est. Completion | 2021-01-28 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03673228
The ClinicalTrials.gov registry entry for NCT03673228 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 21 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is NYU Langone Health, which has 1,164 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 3 interventions - of which Nicotine Replacement Therapy (NRT) is the first listed.
NCT03673228 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03673228 about?
NCT03673228 is a clinical study titled "Preventing Smoking Relapse After Total Joint Replacement Surgery". Hospitalization for elective knee or hip replacement surgery presents an outstanding opportunity to motivate people to quit smoking, because it provides an opportunity to encourage patients to remain smoke-free as they proactively quit to optimize their surgery outcomes. This study will conduct a co...
What is the current status of trial NCT03673228?
This trial is currently completed. It is a NA study. The enrollment target is 21 participants. The study started on 2019-01-15. Estimated completion is 2021-01-28.
What interventions are being tested in trial NCT03673228?
The interventions under investigation include: Nicotine Replacement Therapy (NRT) (DRUG), Standard Treatment Counseling (BEHAVIORAL), Comprehensive Relapse Prevention Intervention (BEHAVIORAL).
Who is sponsoring clinical trial NCT03673228?
This trial is sponsored by NYU Langone Health, which has 1,164 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.